68-4

113/136

) Hamada T, Nakai Y, Isayama H, Koike K: Antireflux metal stent for biliary obstruction: Any benefits? Dig Endosc, 2020.[Epub ahead of print] Review.) Fujisawa T, Ushio M, Takahashi S, Yamagata W, Takasaki Y, Suzuki A, Okawa Y, Ochiai K, Tomishima K, Ishii S, Saito H, Isayama H: Role of Peroral Cholangioscopy in the Diag-nosis of Primary Sclerosing Cholangitis. Diag-nostics (Basel), 2020; 10: E268, Review.) Suzuki M, Minowa K, Isayama H, Shimizu T: Acute Recurrent and Chronic Pancreatitis in Children. Pediatr Int, 2020, Online ahead of print.) Fujisawa T, Isayama H: Immunotherapy for Pancreatic Cancer. Juntendo Medical Journal, Hoteya S, Doyama H, Nagami Y, Hikichi T, Kobayashi M, Morita Y, Sumiyoshi T, Iguchi M, Tomida H, Inoue T, Koike T, Mikami T, Hasatani K, Nishikawa J, Matsumura T, Nebiki H, Nakamatsu D, Ohnita K, Suzuki H, Ueyama H, Hayashi Y, Sugimoto M, Yama-guchi S, Michida T, Yada T, Asahina Y, Nara-saka T, Kuribasyashi S, Kiyotoki S, Mabe K, Nakamura T, Nakaya N, Fujishiro M, Masa-mune A: Prediction model of bleeding after endoscopic submucosal dissection for early gastric cancer: BEST-J score. Gut, 2020. DOI: 10.1136/gutjnl-2019-319926. 66) Akazawa Y, Ueyama H, Tsuyama S, Ikeda A, Yatagai N, Komori H, Takeda T, Matsumoto K, Matsumoto K, Hashimoto T, Tomita N, Kajiyama Y, Kato M, Yao T, Nagahara A: Endoscopic and Clinicopathological Features of Superficial Non-Ampullary Duodenal Tumor Based on the Mucin Phenotypes. Digestion, 2020. doi: 10.1159/000508040. Online ahead of print. 67) Takeda T, Asaoka D, Nojiri S, Nishiyama M, Ikeda A, Yatagai N, Ishizuka K, Hiromoto T, Okubo S, Suzuki M, Nakajima A, Nakatsu Y, Komori H, Akazawa Y, Nakagawa Y, Izumi K, Matsumoto K, Ueyama H, Sasaki H, Shimada Y, Matsumoto K, Osada T, Hojo M, Kato M, Nagahara A: Linked Color Imaging and the Kyoto Classification of Gastritis: Eval-uation of Visibility and Inter-Rater Reli-ability. Digestion, 2020; 101: 598-607. 68) Takeda T, Asaoka D, Abe D, Suzuki M, Nakagawa Y, Sasaki H, Inami Y, Ikemura M, Utsunomiya H, Oki S, Suzuki N, Ikeda A, Yatagai N, Komori H, Akazawa Y, Matsu-moto K, Ueda K, Ueyama H, Shimada Y, Matsumoto K, Hojo M, Osada T, Nojiri S, Nagahara A: Linked color imaging improves visibility of reflux esophagitis. BMC Gastro-enterol, 2020; 20: 356. 69) Nakajima A, Sasaki T, Itoh K, Kitahara T, Takema Y, Hiramatsu K, Ishikawa D, Shibuya T, Kobayashi O, Osada T, Watanabe S, Naga-hara A: A Soluble Fiber Diet Increases Bacte-roides fragilis Group Abundance and Immu-noglobulin A Production in the Gut. Appl Environ Microbiol, 2020; 86: e00405-20. 70) Corridoni D, Antanaviciute A, Gupta T, Fawkner-Corbett D, Aulicino A, Jagielowicz M, Parikh K, Repapi E, Taylor S, Ishikawa D, Hatano R, Yamada T, Xin W, Slawinski H, Bowden R, Napolitani G, Brain O, Morimoto C, Koohy H, Simmons A: Single-cell atlas of colonic CD8+ T cells in ulcerative colitis. Nat Med, 2020; 26: 1480-1490. 71) Okahara K, Ishikawa D, Nomura K, Ito S, Haga K, Takahashi M, Shibuya T, Osada T, Nagahara A: Matching between Donors and Ulcerative Colitis Patients Is Important for Long-Term Maintenance after Fecal Micro-biota Transplantation. J Clin Med, 2020; 9: 1650. 72) Kudo M, Morimoto M, Moriguchi M, Izumi N, Takayama T, Yoshiji H, Hino K, Oikawa T, Chiba T, Motomura K, Kato J, Yasuchika K, Ido A, Sato T, Nakashima D, Ueshima K, Ikeda M, Okusaka T, Tamura K, Furuse J: A randomized, double-blind, placebo-controlled, phase 3 study of tivantinib in Japanese patients with MET-high hepatocellular carcinoma. Cancer Sci, 2020; 111: 3759-3769. doi: 10.1111/cas.14582. Epub 2020. PMID: 32716114 Free PMC article. Clinical Trial. 73) Nakajima A, Sasaki T, Itoh K, Kitahara T, Takema Y, Hiramatsu K, Ishikawa D, Shibuya T, Kobayashi O, Osada T, Watanabe S, Naga-hara A: A soluble fiber diet increases Bacte-roides fragilis group and IgA production in the gut. Appl Environ Microbiol, 2020; 86: e00405-20. doi: 10.1128/AEM.00405-20.〈Reviews〉 1 2 3 4433